Keynote Speaker

Robert Langer, Ph.D., David H. Koch Institute Professor, Massachusetts Institute of Technology

 

Robert Langer

 

Conference Agenda

TUESDAY, APRIL 18

8:00 – 8:15am:  Conference Opening Remarks
8:15 – 8:45am:  Opening Keynote Address from John Lepore, GSK
8:45 – 9:00am:  Break
9:00 – 10:30am:  Development of Long-Acting Injectable and Implantable Products: from FDA and Industry Perspectives

10:30 – 11:00am:  Break
11:00am – 12:30pm:  Novel Controlled-Release Approaches for Peptide and Protein Delivery

12:30 – 1:30pm:  Lunch, Networking and Poster Viewing
1:30 – 3:00pm:  Understanding and Taking Advantage of Biological Dynamics to Design Long-Acting Products
3:00 – 3:30 pm:  Break
3:30 – 5:00pm:  Long-Acting Injectables and Implantables for the Developing World

5:00 – 6:00pm:  Poster Viewing and Refreshments
7:00 – 9:00pm
:  Cocktail Reception


WEDNESDAY, APRIL 19

8:15 – 8:30am:  Opening Remarks
8:30 – 10am:  New Developments in Implant Devices for Reversible Long-Acting Therapy
10:00 – 10:30am:  Break
10:30am – 12:30pm: Emerging Controlled-Release Parenteral Strategies
12:30 – 2:00pm: 
Lunch, Networking, and Poster Viewing
2:00 – 3:00pm:  Closing Keynote Address from
Robert Langer, Ph.D., Massachusetts Institute of Technology
3:00 – 3:30pm:  Conference Closing Remarks

 

Topics

Development of Long-Acting Injectable and Implantable Products: from FDA and Industry Perspectives
Moderators:
  Kamlesh Patel, GSK and Chris Rhodes, Drug Delivery Experts
Thomas Tice, Ph.D., Sr. Director, Evonik Corporation
Yan Wang, Ph.D., Office of Standards and Research, Office of Generic Drugs, FDA
Julius Remenar, Ph.D., Research Fellow, Alkermes


Novel Controlled-Release Approaches for Peptide and Protein Delivery
Moderators:
  Doug Nesta, GSK and Tom Tice, Evonik
Christopher Rhodes, Ph.D., President and CEO, Drug Delivery Experts
Daniel Santi, MD, Ph.D., Associate Dean and Professor, Department of Pharmaceutical Chemistry, School of Pharmacy, University of California - San Francisco and Prolynx
Lasse Leino, Ph.D., CEO, DelSiTech


Understanding and Taking Advantage of Biological Dynamics to Design Long-Acting Products
Moderators: Manish Gupta, GSK and Andrew Owen, University of Liverpool
Randy Mrsny, Ph.D., Professor, Dept. of Pharmacy and Pharmacology, University of Bath
Marco Siccardi, Ph.D., Lecturer, Molecular and Clinical Pharmacology, University of Liverpool
Howard Gendelman, M.D., Margaret R. Larson Professor of Internal Medicine and Infectious Disease, University of Nebraska Medical Center


Long-Acting Injectables and Implantables for the Developing World
Moderators : Sherene Min, ViiV Healthcare and Marc Baum, Oak Crest Institute
Andrew Owen, Ph.D., Professor, Department of Molecular and Clinical Pharmacology, University of Liverpool
Gregory Kopf, Ph.D., Director of Research and Development, Contraceptive Technology and Innovation, FHI 360
William Spreen, Pharm.D., Vice President, Medicine Development Leader, ViiV Healthcare


New Developments in Implant Devices for Reversible Long-Acting Therapy
Moderators:  William Spreen , ViiV Healthcare and Greg Kopf, FHI 360
Alex Schwarz, Ph.D., Vice President, Early Development, Braeburn Pharmaceuticals
Marc Baum, Ph.D., President, Oak Crest Institute
Cheryl Blanchard, Ph.D., President and CEO, Microchips Biotech


Emerging Controlled-Release Parenteral Strategies 
Moderators:  Matt Burke, GSK and Randy Mrsny, University of Bath
Omid Veiseh, Ph.D., Assistant Professor of Bioengineering, CPRIT Scholar in Cancer Research, Rice University
Robert Prud'homme, Ph.D., Professor of Chemical and Biological Engineering, Princeton
David Mooney, Ph.D., Robert P. Pinkas Family Professor of Bioengineering, Wyss Institute, Harvard
Steven Schwendeman, Ph.D., Chair and Ara G. Paul Professor of Pharmaceutical Sciences, College of Pharmacy, and Professor of Biomedical Engineering, College of Engineering, University of Michigan

 

Abstract Information

Abstract submission has closed for this conference. Acceptance letters will be sent soon so stay tuned! If you have any questions about an abstract that you submitted, please contact Brianna Plank.

 

Hotel Venue

Courtyard Philadelphia South at the Navy Yard
1001 Intrepid Ave
Philadelphia, PA, 19112
U.S.A. 

HOTEL UPDATE: rooms at the Courtyard Philadelphia at the GSK rate are now SOLD OUT. We have other hotel arrangements for those who have not yet made their reservation - please contact Brianna Plank to book your stay for the conference if you have not already.

 

Other Information

If you have any dietary restrictions, physical limitations, life-threatening allergies, or other important requests, please contact Brianna Plank so we can appropriately accommodate your needs.

 

Registration Rates

Meeting Registration Types Rates ($USD) 

Abstract Presenter

$595

GSK Employee

$595

Regular Attendee

$695




Space is very limited – register now!


© Copyright Controlled Release Society  | Contact Us - Report a Bad Link